318) Aside from those associated with revenue, motivations |
319) triggered grief, and what can be done (by those not diagnosed with complicated grief |
320) t pneumococcal conjugate vaccine (PCV13), those not included (non-PCV13) and the six |
321) not been found to protect body image, and those not sufficiently evaluated. |
322) rch with keywords "moyamoya case report," those reported from a Western institution, |
323) our findings are essentially identical to those reported originally. |
324) usability-conclusions that closely mirror those reported outside of Psychology. |
325) sets of principles poses a challenge for those seeking to critically engage with an |
326) oned to test and disseminate the model to those seeking to introduce WSCC in their s |
327) bilitation, and may act as a resource for those seeking to understand the precedence |
328) Those studies were grouped into three cate |
329) Among the 439 metabolites reported in those studies as able to discriminate AP- |
330) In those studies displaying a comparator popu |
331) eved if integrated care strategies target those at highest risk for HCV infection an |
332) ention studies targeting mental health in those at risk of severe COVID-19 infection |
333) ID-19 faced by older people, specifically those belonging to certain subgroups. |
334) cies less frequently affected compared to those belonging to the Bos taurus subspeci |
335) ement in primary care settings, including those developed or led by pharmacists, or |
336) e physiologic targets of drugs, including those developed with target-based strategi |
337) tiate GGOs due to COVID-19 pneumonia from those due to other acute lung diseases. |
338) to discriminate GGOs due to COVID-19 from those due to other acute lung diseases. |
339) bit Harderian gland and tears differ from those identified in human meibum and tears |
340) Among those identified to be increased by TG, 15 |
341) with altered CpG sites were enriched with those involved in development, including c |
342) easible, impactful and empowering for all those involved. |
343) e of trial evidence for interventions for those most affected by their shift-work sc |
344) ediatric brain tumors, particularly among those most at-risk for poor outcomes. |
345) ed decision-making (SDM) helps to address those needs and promote informed value-bas |
346) itutions, and the factors associated with those needs. |
347) te CNMA models and compare the results to those obtained by Schmitz et al. |
348) seven-site method would be different from those obtained by three-site measurement t |
349) CBCT images were collected from those patients who received proton therapy |
350) lum at 3 months post-SAH were present to those patients with worse cognitive outcom |
|